The latest news about psychopharmacology and drug research
The psychedelic drug psilocybin could help alleviate depression by causing people to have a less…
New neuroimaging research provides new insight into how tetrahydrocannabinol, or THC, the main psychoactive compound…
There has been a renewed scientific interest in the use of psychedelics and preliminary evidence…
A substance found in cannabis may be a faster-acting antidepressant than conventional medications. A new…
The link between cannabis use and psychological distress is stronger for women than men, according…
Studies have found an association between cannabis use and transient psychotic symptoms, such as unusual…
A new study provides evidence that regular caffeine consumption is associated with alterations in the…
A substance found in chili peppers reduces depressive symptoms in a rodent model of depression,…
New research helps identify some of the differences between the cognitive effects of classical hallucinogens…
Alcohol intoxication can impair the ability of witnesses to properly recall a person’s facial characteristics,…
The anti-anxiety effects of ketamine are associated with specific brainwave changes, according to research published…
Many people report persisting positive effects after receiving ibogaine-assisted detoxification for opioid addiction, but many…
New research provides evidence that a person’s religious beliefs can shape their experiences with psychedelic…
A new study sought to identify some of the potential psychological mechanisms that lead to smoking cessation in people who received psilocybin, the active compound in so-called magic mushrooms.
Synthetic cannabinoids can increase depression- and anxiety-like behaviors in a rodent model of trauma, according…